These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32505432)

  • 1. Does COVID-19 cause axonal GBS?
    Umapathi T
    J Clin Neurosci; 2020 Aug; 78():448. PubMed ID: 32505432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter to the editor. Concerning the article entitled ''Guillain Barre syndrome associated with COVID-19 infection: A case report".
    Karimi N; Sedaghat Z
    J Clin Neurosci; 2020 Sep; 79():257-258. PubMed ID: 33070907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and Guillain-Barré syndrome.
    Joob B; Wiwanitkit V
    Rev Neurol (Paris); 2020 Sep; 176(7):637. PubMed ID: 32410748
    [No Abstract]   [Full Text] [Related]  

  • 4. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
    Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
    Agha Abbaslou M; Karbasi M; Mozhdehipanah H
    Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post SARS-CoV-2 Guillain-Barré syndrome.
    Arnaud S; Budowski C; Ng Wing Tin S; Degos B
    Clin Neurophysiol; 2020 Jul; 131(7):1652-1654. PubMed ID: 32422529
    [No Abstract]   [Full Text] [Related]  

  • 7. Guillain-Barré syndrome after covid-19 infection.
    García-Manzanedo S; López de la Oliva Calvo L; Ruiz Álvarez L
    Med Clin (Barc); 2020 Oct; 155(8):366. PubMed ID: 32718718
    [No Abstract]   [Full Text] [Related]  

  • 8. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
    Zhao H; Shen D; Zhou H; Liu J; Chen S
    Lancet Neurol; 2020 May; 19(5):383-384. PubMed ID: 32246917
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.
    Yesilkaya UH; Balcioglu YH
    J Clin Neurosci; 2020 Aug; 78():449-450. PubMed ID: 32505431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome related to COVID-19 infection.
    Alberti P; Beretta S; Piatti M; Karantzoulis A; Piatti ML; Santoro P; Viganò M; Giovannelli G; Pirro F; Montisano DA; Appollonio I; Ferrarese C
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32350026
    [No Abstract]   [Full Text] [Related]  

  • 12. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection.
    Coen M; Jeanson G; Culebras Almeida LA; Hübers A; Stierlin F; Najjar I; Ongaro M; Moulin K; Makrygianni M; Leemann B; Kronig I; Bertrand J; Reny JL; Schibler M; Serratrice J
    Brain Behav Immun; 2020 Jul; 87():111-112. PubMed ID: 32360440
    [No Abstract]   [Full Text] [Related]  

  • 13. Guillain-Barré Syndrome Associated with SARS-CoV-2.
    Toscano G; Palmerini F; Ravaglia S; Ruiz L; Invernizzi P; Cuzzoni MG; Franciotta D; Baldanti F; Daturi R; Postorino P; Cavallini A; Micieli G
    N Engl J Med; 2020 Jun; 382(26):2574-2576. PubMed ID: 32302082
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2-Associated Guillain-Barre Syndrome With Good Response to Plasmapheresis.
    Granger A; Omari M; Jakubowska-Sadowska K; Boffa M; Zakin E
    J Clin Neuromuscul Dis; 2020 Sep; 22(1):58-59. PubMed ID: 32833726
    [No Abstract]   [Full Text] [Related]  

  • 15. Guillain Barre syndrome associated with COVID-19 infection: A case report.
    Sedaghat Z; Karimi N
    J Clin Neurosci; 2020 Jun; 76():233-235. PubMed ID: 32312628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
    Uncini A; Vallat JM; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
    Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
    J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Coronavirus (COVID-19)-Associated Guillain-Barré Syndrome: Case Report.
    Rana S; Lima AA; Chandra R; Valeriano J; Desai T; Freiberg W; Small G
    J Clin Neuromuscul Dis; 2020 Jun; 21(4):240-242. PubMed ID: 32453100
    [No Abstract]   [Full Text] [Related]  

  • 19. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
    Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
    Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2.
    Bracaglia M; Naldi I; Govoni A; Brillanti Ventura D; De Massis P
    J Neurol; 2020 Nov; 267(11):3166-3168. PubMed ID: 32588185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.